Results 161 to 170 of about 86,601 (293)

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer

Cancer Science, EarlyView.
The combination of cladribine and irradiation significantly suppressed the growth of DU145‐derived tumors compared with the DMSO plus irradiation group in the mouse model. In addition, it also elevated the percentage of γH2AX‐positive cells after irradiation.
Toshiki Oka, Koji Hatano, Shohei Katsuki, Tomohiro Kanaki, Shunsuke Inoguchi, Masaru Tani, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Yohei Okuda, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Yu Ishizuya, Takuji Hayashi, Yoshiyuki Yamamoto, Taigo Kato, Atsunari Kawashima, Keisuke Tamari, Bangzhong Lin, Akiyoshi Tani, Kazutake Tsujikawa, Yutaka Takahashi, Kazuhiko Ogawa, Shawn E. Lupold, Norio Nonomura   +26 more
wiley   +1 more source

Occupational, Lifestyle, and Medical Risk Factors for Non-Hodgkin Lymphoma: A Case-Control Study in Ethiopia. [PDF]

Cancers (Basel)
Baissa OT, Abdela F, Tadesse F, Damie A, Sori M, Hailu W, Bizuneh S, Abebe B, Adamu B, Amir G, Paltiel O.   +10 more
europepmc   +1 more source

Breast T-Cell Non-Hodgkin Lymphoma [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene‐engineered advanced cell therapy products for treatment of haematological disorders

British Journal of Haematology, EarlyView.
S. Ghorashian, R. Sanderson, J. Lee, A. Black, M. A. O'Reilly, D. I. Marks, J. Snowden, D. Richardson, E. Olavarria   +8 more
wiley   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Non-Hodgkin Lymphoma and Tuberculosis Coexisting in the Same Cervical Lymph Node: A Case Report. [PDF]

Cureus
Taha A, Alzhrani S, Aljafari N, Aljadani BA, Al-Rashdi A, Almuntashiri AA, Alkhalifah KM, Bahshwan W.   +7 more
europepmc   +1 more source

Survival from non-Hodgkin lymphoma in England and Wales up to 2001 [PDF]

, 2008
Peter Johnson
openalex   +1 more source

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

HERV-K Envelope Induce a Humoral Response in Non-Hodgkin Lymphoma Patients. [PDF]

Curr Microbiol
Cossu I, Ruberto S, Filippi E, Simula ER, Noli M, Mottula A, Fozza C, Sechi LA.   +7 more
europepmc   +1 more source

Tyrosine kinase inhibitor and rituximab‐ CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report [PDF]

, 2017
Yuki Takeyasu, Atsushi� Satake, Yoshiko� Azuma, Yukie� Tsubokura, Hideaki� Yoshimura, Masaaki� Hotta, Takahisa� Nakanishi, Shinya� Fujita, Aya Nakaya, Tomoki� Ito, Shosaku� Nomura   +10 more
openalex   +1 more source